Selective Photokilling of Human Pancreatic Cancer Cells Using Cetuximab-Targeted Mesoporous Silica Nanoparticles for Delivery of Zinc Phthalocyanine.
Özge ErSuleyman Gokhan ColakKasim OcakogluMine InceRoger Bresoli-ObachMargarita MoraMaria Lluïsa SagristáFatma YurtSanti NonellPublished in: Molecules (Basel, Switzerland) (2018)
Imidazole-capped Cetuximab-targeted mesoporous silica nanoparticles are excellent vehicles for the selective delivery of ZnPcOBP to pancreatic cancer cells expressing the EGFR receptor. The novel nanosystem appears to be a suitable agent for photodynamic therapy of pancreatic tumors.